Ocular Surgery News U.S. Edition Current Issue
The following articles appeared in the print edition of Ocular Surgery News U.S. Edition.
Table of Contents
- Lack of testing for generic ophthalmic drugs seen as problematic by some experts
-
- Improving toric IOL outcomes, part 1 Jack T. Holladay, MD, MSEE, FACS
- Intravitreal anti-VEGF yields significant benefit in treatment of stage 3+ ROP
- Kiawah Eye 2011 features answers to everyday challenges
- Merck announces plan to acquire Inspire Pharmaceuticals
- PDF of Improving toric IOL outcomes article
- Reformulated NSAID reduces pain, inflammation after cataract surgery
- Round table: Are physicians ready to adopt intravitreal bevacizumab as routine treatment for ROP?
- Should patients taking generic medications be managed any differently than patients taking brand medications?
-
- Surgeon gives tips for combined glaucoma, phaco procedure
- Cataract quiz for residents, part 3 Uday Devgan, MD
- Generic substitutions may be more costly in the long run Richard L. Lindstrom, MD
- Man presents with visual complaints after laser peripheral iridotomy in left eye Laurel N. Vuong, MD; Cynthia G. Mattox, MD
- DSAEK after previous failed PK yields low graft dislocation rate
- Refractive surgery improves amblyopia in older children
- Speaker counsels colleagues on stem cell treatment for pediatric vision brain disease
- Two knotting techniques can be used to relocate single-piece foldable IOLs Suven Bhattacharjee, MS, DO, DNB
-